Pulmonary CT angiograms that detect coronary artery calcification can help predict acute coronary syndrome in some patients
Coronary artery calcification (CAC) is a significant predictor of acute coronary syndrome (ACS), particularly among certain groups of patients, according to a study published in the American Journal of Roentgenology.
Researchers from Massachusetts General Hospital and Harvard Medical School sought to evaluate the frequency of unreported CAC and its association with a diagnosis of ACS. To do this, they obtained data from 469 patients who underwent emergency pulmonary CT angiography for suspected pulmonary thromboembolism.
Positive findings for CAC were recorded, all pulmonary CT angiograms were reevaluated by a radiologist and findings of CAC were recorded.
The findings showed that approximately 11.1 percent of the patients who underwent the pulmonary CT angiograms did have a pulmonary thromboembolism and 43.8 percent had CAC. “The incidence of CAC was significantly higher in patients with an ACS diagnosis than without ACS (56.2 percent versus 40.4 percent, respectively),” wrote the authors.
Men who were 45 years old or younger and women 55 years old or younger had a positive association between CAC and ACS, as did those without cardiometabolic factors.
Ninety-eight of the patients (45 percent) had positive CAC, but it had not been reported. ACS was diagnosed in 31.6 percent of patients among whom CAC had not been reported. “There was a significant association between CAC and ACS in patients with unreported CAC,” the researchers noted, with the association being more prominent in the subgroups described.
The researchers concluded that although CAC is often not reported in pulmonary CT angiography studies, it “is a significant predictor of ACS particularly in younger patients, patients without pulmonary thromboembolism, and those without cardiometabolic risk factors.” They recommend that radiologists should assess CAC findings, especially in these subgroups.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.